NR4A1 and neoplasm: Given that HGF positivity may ultimately be clinically targetable and is correlated with a number of poor prognosis clinical characteristics in both basal-like and non-basal-like tumors (including tumor stage, hormone receptor-negative markers, stage, tumor grade, and higher risk of recurrence scores), it is important to understand its distribution and contribution to outcomes.